Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Podophyllum, particularly its resin (podophyllin), has been studied for its antiviral properties and is most commonly used topically for the treatment of anogenital warts caused by human papillomavirus (HPV). Its mechanism involves inhibition of cell mitosis, leading to local tissue necrosis. While there is a strong body of scientific evidence supporting its use for genital warts, evidence supporting its use for herpes simplex virus (HSV) infections is limited and not robust. Some older studies and anecdotal reports have explored podophyllum as a topical agent for herpes lesions, given its caustic effects and antiviral activity in vitro. However, clinical trials and systematic reviews do not support its routine use for herpes. Modern medical guidelines do not recommend podophyllum for herpes simplex infections due to insufficient efficacy and the potential for significant local irritation and toxicity. Instead, antiviral medications such as acyclovir, valacyclovir, and famciclovir are preferred. In summary, while there is some historical and limited early scientific interest in podophyllum for herpes, the evidence is weak (rated 2/5), and it is not a recommended or standard treatment for HSV infections.

More about Podophyllum
More about Herpes

Other ingredients used for Herpes

Other health conditions supported by Podophyllum

Products containing Podophyllum